- Specialty
-
Oncologist, lung expert
- Title
-
Head of department
- Hospital
-
AP-HM Hôpital Nord (Marseille)
- Latest articles
-
-
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08-2015 ENERGY): a randomised, open-label, phase 3 study.
(Feb 1, 2025)
-
Lack of Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer in Real Life, with the Emergence of Immunotherapy.
(Dec 9, 2024)
-
A pilot quality improvement initiative for lymph node dissection during lung cancer surgery.
(Nov 28, 2024)
-
Predictive biomarkers for immune checkpoint efficacy: is multi-omics breaking the deadlock?
(Oct 31, 2024)
-
Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC.
(Oct 19, 2024)
